Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Average Recommendation of “Hold” from Analysts

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have been given a consensus recommendation of “Hold” by the five analysts that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating on the company. The average 1-year price objective among brokers that have covered the stock in the last year is $4.00.

Several research firms have recently weighed in on BIOX. Wall Street Zen upgraded shares of Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd. Oppenheimer cut shares of Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a research report on Wednesday, October 22nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Monday, December 29th. Finally, Canaccord Genuity Group dropped their price target on Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating on the stock in a research note on Friday, January 2nd.

Bioceres Crop Solutions Trading Down 6.7%

NASDAQ:BIOX opened at $1.26 on Friday. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.94 and a quick ratio of 0.64. The business’s 50-day simple moving average is $1.54 and its 200-day simple moving average is $2.35. Bioceres Crop Solutions has a fifty-two week low of $1.20 and a fifty-two week high of $7.44. The stock has a market capitalization of $79.67 million, a PE ratio of -1.50 and a beta of 0.47.

Hedge Funds Weigh In On Bioceres Crop Solutions

Large investors have recently bought and sold shares of the company. Bank of America Corp DE grew its stake in shares of Bioceres Crop Solutions by 186.8% during the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after acquiring an additional 3,735 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Bioceres Crop Solutions by 9.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 823,916 shares of the company’s stock worth $3,761,000 after purchasing an additional 71,581 shares during the last quarter. Jones Financial Companies Lllp grew its position in Bioceres Crop Solutions by 3,535.8% in the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after purchasing an additional 5,339 shares in the last quarter. Avanza Fonder AB increased its stake in Bioceres Crop Solutions by 62.9% in the 2nd quarter. Avanza Fonder AB now owns 26,164 shares of the company’s stock valued at $117,000 after buying an additional 10,099 shares during the last quarter. Finally, Ardsley Advisory Partners LP lifted its position in Bioceres Crop Solutions by 4.7% during the 2nd quarter. Ardsley Advisory Partners LP now owns 993,614 shares of the company’s stock worth $4,441,000 after buying an additional 45,000 shares in the last quarter. Institutional investors and hedge funds own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.